Bruker Corp (BRKRP) stock
BRKRPNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKR
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30440% above fair value
$442.19−17.24 (-3.75%)
Close on Nov 12, 2026Market cap $9.36BP/E –Yield –
Bruker EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Bruker's EPS for the twelve months ending Sep 30, 2026 was -$1.10. For fiscal 2025 it was -$0.15, down 119.7% from the year before. The highest annual figure on record is $2.90 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.15 | -119.7% |
| FY2024 | Dec 31, 2024 | $0.76 | -73.8% |
| FY2023 | Dec 31, 2023 | $2.90 | +45.7% |
| FY2022 | Dec 31, 2022 | $1.99 | +9.9% |
| FY2021 | Dec 31, 2021 | $1.81 | +77.5% |
| FY2020 | Dec 31, 2020 | $1.02 | -19.0% |
| FY2019 | Dec 31, 2019 | $1.26 | +10.5% |
| FY2018 | Dec 31, 2018 | $1.14 | +132.7% |
| FY2017 | Dec 31, 2017 | $0.49 | -48.4% |
| FY2016 | Dec 31, 2016 | $0.95 | +58.3% |
| FY2015 | Dec 31, 2015 | $0.60 | +81.8% |
| FY2014 | Dec 31, 2014 | $0.33 | -31.2% |
| FY2013 | Dec 31, 2013 | $0.48 | +4.3% |
| FY2012 | Dec 31, 2012 | $0.46 | -16.4% |
| FY2011 | Dec 31, 2011 | $0.55 | -5.2% |
| FY2010 | Dec 31, 2010 | $0.58 | +18.4% |
| FY2009 | Dec 31, 2009 | $0.49 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.81 | – |
| Q2 FY2026 | Jun 30, 2026 | -$0.41 | -920.0% |
| Q1 FY2026 | Mar 31, 2026 | $0.02 | -81.8% |
| Q4 FY2025 | Dec 31, 2025 | $0.10 | +11.1% |
| Q3 FY2025 | Sep 30, 2025 | -$0.41 | -251.9% |
| Q2 FY2025 | Jun 30, 2025 | $0.05 | 0.0% |
| Q1 FY2025 | Mar 31, 2025 | $0.11 | -68.6% |
| Q4 FY2024 | Dec 31, 2024 | $0.09 | -85.0% |
| Q3 FY2024 | Sep 30, 2024 | $0.27 | -30.8% |
| Q2 FY2024 | Jun 30, 2024 | $0.05 | -90.4% |
| Q1 FY2024 | Mar 31, 2024 | $0.35 | -40.7% |
| Q3 FY2023 | Sep 30, 2023 | $0.60 | +81.8% |
| Q2 FY2023 | Jun 30, 2023 | $0.39 | -4.9% |
| Q1 FY2023 | Mar 31, 2023 | $0.52 | -8.8% |
| Q3 FY2022 | Sep 30, 2022 | $0.59 | +55.3% |
| Q2 FY2022 | Jun 30, 2022 | $0.33 | -10.8% |
| Q1 FY2022 | Mar 31, 2022 | $0.41 | +17.1% |
| Q3 FY2021 | Sep 30, 2021 | $0.57 | +256.2% |
| Q2 FY2021 | Jun 30, 2021 | $0.38 | +442.9% |
| Q1 FY2021 | Mar 31, 2021 | $0.37 | -15.9% |
| Q3 FY2020 | Sep 30, 2020 | $0.35 | -10.3% |
| Q2 FY2020 | Jun 30, 2020 | $0.16 | -30.4% |
| Q1 FY2020 | Mar 31, 2020 | $0.07 | -65.0% |
| Q4 FY2019 | Dec 31, 2019 | $0.44 | -12.0% |
| Q3 FY2019 | Sep 30, 2019 | $0.39 | +39.3% |
| Q2 FY2019 | Jun 30, 2019 | $0.23 | +15.0% |
| Q1 FY2019 | Mar 31, 2019 | $0.20 | +17.6% |
| Q4 FY2018 | Dec 31, 2018 | $0.50 | – |
| Q3 FY2018 | Sep 30, 2018 | $0.28 | +21.7% |
| Q2 FY2018 | Jun 30, 2018 | $0.20 | +33.3% |
| Q1 FY2018 | Mar 31, 2018 | $0.17 | +30.8% |
| Q4 FY2017 | Dec 31, 2017 | -$0.02 | -104.7% |
| Q3 FY2017 | Sep 30, 2017 | $0.23 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.15 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.13 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.43 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?